Products/Services Used | Details | Operation |
---|---|---|
Gene Synthesis> | Specific primers sequences were offered by the Genscript Biological Technology Company (Nanjing, China) as follows: TNF-α primer [50’-AAATGGGCTCCCTCTCATCAGTTC-30’ (forward) and 50’-TCTGCTTGGTGGTTTGCTACGAC-30’ (reverse)], IL-1β primers [50’ -CACCTCTCAAGCAGAGCACAG-30’ (forward) and 50’-GGGTTCCATGGTGAAGTCAAC-30’ (reverse)], IL-6 primers [50’-TCCTACCCCAACTTCCAATGCTC-30’ (forward) and 50’-TTGGATGGTCTTGGTCCTTAGCC-30’ (reverse)], CCL-2 primers [5’-TTGTCACCAAGCTCAAGAGAGA-3’ (forward) and 5’-GAGGTGGTTGTGGAAAAGGTAG-3’ (reverse)] and GAPDH primers [5’-ACAGCAACAGGGTGGTGGAC-3’ (forward) and 5’-TTT GAGGGTGCAGCGAACTT-3’ (reverse)]. Data were analyzed using the Line-Gene software. The expression levels of target mRNA were calculated with the 2-∆∆Ct method and normalized by against mouse GAPDH gene. Page 26 of 46 ACS P | Get A Quote |
Early brain injury (EBI) after aneurysmal subarachnoid hemorrhage (SAH) contributes to high morbidity and mortality. Although it is well recognized that acute neuroinflammation reaction is one of the most important triggers of EBI, pharmacotherapy proved to be clinically effective against the initiating of neuroinflammation after SAH is lacking. The resident microglia and infiltrated peripheral monocyte are two main types of immune cells in central nervous system (CNS) and control the inflammation process in brain after SAH. But the time course and relative contributions of these two immune cell activations after SAH are unknown. The p75 neurotrophin receptor (p75NTR), member of TNF receptor... More